Gozeler, Mustafa Sitki <br/><br/>
Levosimendan ameliorates cisplatin-induced ototoxicity: Rat model.  [electronic resource] 

 -  International journal of pediatric otorhinolaryngology  Jul 2019 
 - 70-75 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1872-8464 
<br/><br/><label>Standard No.: </label>10.1016/j.ijporl.2019.04.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>8-Hydroxy-2'-Deoxyguanosine<br/>Animals<br/>Antineoplastic Agents--adverse effects<br/>Apoptosis--drug effects<br/>Caspase 3--metabolism<br/>Cisplatin--adverse effects<br/>Cochlea--metabolism<br/>Deoxyguanosine--analogs & derivatives<br/>Disease Models, Animal<br/>Female<br/>Glutathione Peroxidase--metabolism<br/>Hearing--drug effects<br/>Hearing Loss--chemically induced<br/>Malondialdehyde--metabolism<br/>Otoacoustic Emissions, Spontaneous--drug effects<br/>Oxidative Stress--drug effects<br/>Phosphodiesterase 3 Inhibitors--therapeutic use<br/>Random Allocation<br/>Rats<br/>Rats, Sprague-Dawley<br/>Signal-To-Noise Ratio<br/>Simendan--therapeutic use<br/>Superoxide Dismutase--metabolism